AR

Alex Rosen

Managing Partner at Spruce Street Capital LP

New York, New York

Overview

Work Experience

SS

Spruce Street Capital LP

  • Managing Partner

    2024 - Current

UB

Upstream Bio

  • Board Member

    2023 - 2023

V

Venrock

  • Partner

    2020 - 2023

  • Biotech investor

    2016 - 2023

    Public and private/crossover biotechnology investing

R

RayzeBio

  • Board Member

    2022 - 2023

    IPO Sep 2023 (NASDAQ: RYZB) acquired by Bristol Myers Squibb for $4.1 billion, Dec 2023

RP

Regeneron Pharmaceuticals, Inc.

  • Business Development

    2015 - 2015

M&

McKinsey & Company

  • Summer Associate

    2014 - 2014

Education

Latest Articles

Medium•May 2022

Top 10 Listicle

Talks about Com 250, Listicles and online news consumption

Relevant Websites